OTC Veterinary Drug - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511248624

Publication Date:

November 5, 2024

Pages:

106

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Over-the-counter (OTC) veterinary drugs are medications that can be purchased directly by pet owners without a prescription from a veterinarian. These medications are typically used for the treatment and management of minor health conditions in animals.
The global market for OTC Veterinary Drug was estimated to be worth US$ 8421 million in 2023 and is forecast to a readjusted size of US$ 13890 million by 2030 with a CAGR of 7.9% during the forecast period 2024-2030
The increased demand for un-prescribed veterinary drugs, higher pet adoption, and humanization, expanding pet accessories, and vet medical stores are flourishing the demand for over-the-cover veterinary drugs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for OTC Veterinary Drug, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of OTC Veterinary Drug by region & country, by Type, and by Application.
The OTC Veterinary Drug market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Veterinary Drug.
麻豆原创 Segmentation
By Company
Zoetis
Boehringer Ingelheim
Virbac S.A.
Hester Biosciences Ltd.
Merck Animal Health
Elanco Animal Health
Ceva Sant茅 Animale
Vetoquinol S.A.
Phibro Animal Health Corporation
Dechra Pharmaceuticals PLC
Segment by Type:
Oral
Injectable
Topical
Others
Segment by Application
Veterinary Hospitals
Veterinary Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of OTC Veterinary Drug manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of OTC Veterinary Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of OTC Veterinary Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 OTC Veterinary Drug Product Introduction
1.2 Global OTC Veterinary Drug 麻豆原创 Size Forecast
1.3 OTC Veterinary Drug 麻豆原创 Trends & Drivers
1.3.1 OTC Veterinary Drug Industry Trends
1.3.2 OTC Veterinary Drug 麻豆原创 Drivers & Opportunity
1.3.3 OTC Veterinary Drug 麻豆原创 Challenges
1.3.4 OTC Veterinary Drug 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global OTC Veterinary Drug Players Revenue Ranking (2023)
2.2 Global OTC Veterinary Drug Revenue by Company (2019-2024)
2.3 Key Companies OTC Veterinary Drug Manufacturing Base Distribution and Headquarters
2.4 Key Companies OTC Veterinary Drug Product Offered
2.5 Key Companies Time to Begin Mass Production of OTC Veterinary Drug
2.6 OTC Veterinary Drug 麻豆原创 Competitive Analysis
2.6.1 OTC Veterinary Drug 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by OTC Veterinary Drug Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Veterinary Drug as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oral
3.1.2 Injectable
3.1.3 Topical
3.1.4 Others
3.2 Global OTC Veterinary Drug Sales Value by Type
3.2.1 Global OTC Veterinary Drug Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global OTC Veterinary Drug Sales Value, by Type (2019-2030)
3.2.3 Global OTC Veterinary Drug Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Veterinary Hospitals
4.1.2 Veterinary Clinics
4.1.3 Others
4.2 Global OTC Veterinary Drug Sales Value by Application
4.2.1 Global OTC Veterinary Drug Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global OTC Veterinary Drug Sales Value, by Application (2019-2030)
4.2.3 Global OTC Veterinary Drug Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global OTC Veterinary Drug Sales Value by Region
5.1.1 Global OTC Veterinary Drug Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global OTC Veterinary Drug Sales Value by Region (2019-2024)
5.1.3 Global OTC Veterinary Drug Sales Value by Region (2025-2030)
5.1.4 Global OTC Veterinary Drug Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America OTC Veterinary Drug Sales Value, 2019-2030
5.2.2 North America OTC Veterinary Drug Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe OTC Veterinary Drug Sales Value, 2019-2030
5.3.2 Europe OTC Veterinary Drug Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific OTC Veterinary Drug Sales Value, 2019-2030
5.4.2 Asia Pacific OTC Veterinary Drug Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America OTC Veterinary Drug Sales Value, 2019-2030
5.5.2 South America OTC Veterinary Drug Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa OTC Veterinary Drug Sales Value, 2019-2030
5.6.2 Middle East & Africa OTC Veterinary Drug Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions OTC Veterinary Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions OTC Veterinary Drug Sales Value
6.3 United States
6.3.1 United States OTC Veterinary Drug Sales Value, 2019-2030
6.3.2 United States OTC Veterinary Drug Sales Value by Type (%), 2023 VS 2030
6.3.3 United States OTC Veterinary Drug Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe OTC Veterinary Drug Sales Value, 2019-2030
6.4.2 Europe OTC Veterinary Drug Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe OTC Veterinary Drug Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China OTC Veterinary Drug Sales Value, 2019-2030
6.5.2 China OTC Veterinary Drug Sales Value by Type (%), 2023 VS 2030
6.5.3 China OTC Veterinary Drug Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan OTC Veterinary Drug Sales Value, 2019-2030
6.6.2 Japan OTC Veterinary Drug Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan OTC Veterinary Drug Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea OTC Veterinary Drug Sales Value, 2019-2030
6.7.2 South Korea OTC Veterinary Drug Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea OTC Veterinary Drug Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia OTC Veterinary Drug Sales Value, 2019-2030
6.8.2 Southeast Asia OTC Veterinary Drug Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia OTC Veterinary Drug Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India OTC Veterinary Drug Sales Value, 2019-2030
6.9.2 India OTC Veterinary Drug Sales Value by Type (%), 2023 VS 2030
6.9.3 India OTC Veterinary Drug Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Zoetis
7.1.1 Zoetis Profile
7.1.2 Zoetis Main Business
7.1.3 Zoetis OTC Veterinary Drug Products, Services and Solutions
7.1.4 Zoetis OTC Veterinary Drug Revenue (US$ Million) & (2019-2024)
7.1.5 Zoetis Recent Developments
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Profile
7.2.2 Boehringer Ingelheim Main Business
7.2.3 Boehringer Ingelheim OTC Veterinary Drug Products, Services and Solutions
7.2.4 Boehringer Ingelheim OTC Veterinary Drug Revenue (US$ Million) & (2019-2024)
7.2.5 Boehringer Ingelheim Recent Developments
7.3 Virbac S.A.
7.3.1 Virbac S.A. Profile
7.3.2 Virbac S.A. Main Business
7.3.3 Virbac S.A. OTC Veterinary Drug Products, Services and Solutions
7.3.4 Virbac S.A. OTC Veterinary Drug Revenue (US$ Million) & (2019-2024)
7.3.5 Hester Biosciences Ltd. Recent Developments
7.4 Hester Biosciences Ltd.
7.4.1 Hester Biosciences Ltd. Profile
7.4.2 Hester Biosciences Ltd. Main Business
7.4.3 Hester Biosciences Ltd. OTC Veterinary Drug Products, Services and Solutions
7.4.4 Hester Biosciences Ltd. OTC Veterinary Drug Revenue (US$ Million) & (2019-2024)
7.4.5 Hester Biosciences Ltd. Recent Developments
7.5 Merck Animal Health
7.5.1 Merck Animal Health Profile
7.5.2 Merck Animal Health Main Business
7.5.3 Merck Animal Health OTC Veterinary Drug Products, Services and Solutions
7.5.4 Merck Animal Health OTC Veterinary Drug Revenue (US$ Million) & (2019-2024)
7.5.5 Merck Animal Health Recent Developments
7.6 Elanco Animal Health
7.6.1 Elanco Animal Health Profile
7.6.2 Elanco Animal Health Main Business
7.6.3 Elanco Animal Health OTC Veterinary Drug Products, Services and Solutions
7.6.4 Elanco Animal Health OTC Veterinary Drug Revenue (US$ Million) & (2019-2024)
7.6.5 Elanco Animal Health Recent Developments
7.7 Ceva Sant茅 Animale
7.7.1 Ceva Sant茅 Animale Profile
7.7.2 Ceva Sant茅 Animale Main Business
7.7.3 Ceva Sant茅 Animale OTC Veterinary Drug Products, Services and Solutions
7.7.4 Ceva Sant茅 Animale OTC Veterinary Drug Revenue (US$ Million) & (2019-2024)
7.7.5 Ceva Sant茅 Animale Recent Developments
7.8 Vetoquinol S.A.
7.8.1 Vetoquinol S.A. Profile
7.8.2 Vetoquinol S.A. Main Business
7.8.3 Vetoquinol S.A. OTC Veterinary Drug Products, Services and Solutions
7.8.4 Vetoquinol S.A. OTC Veterinary Drug Revenue (US$ Million) & (2019-2024)
7.8.5 Vetoquinol S.A. Recent Developments
7.9 Phibro Animal Health Corporation
7.9.1 Phibro Animal Health Corporation Profile
7.9.2 Phibro Animal Health Corporation Main Business
7.9.3 Phibro Animal Health Corporation OTC Veterinary Drug Products, Services and Solutions
7.9.4 Phibro Animal Health Corporation OTC Veterinary Drug Revenue (US$ Million) & (2019-2024)
7.9.5 Phibro Animal Health Corporation Recent Developments
7.10 Dechra Pharmaceuticals PLC
7.10.1 Dechra Pharmaceuticals PLC Profile
7.10.2 Dechra Pharmaceuticals PLC Main Business
7.10.3 Dechra Pharmaceuticals PLC OTC Veterinary Drug Products, Services and Solutions
7.10.4 Dechra Pharmaceuticals PLC OTC Veterinary Drug Revenue (US$ Million) & (2019-2024)
7.10.5 Dechra Pharmaceuticals PLC Recent Developments
8 Industry Chain Analysis
8.1 OTC Veterinary Drug Industrial Chain
8.2 OTC Veterinary Drug Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 OTC Veterinary Drug Sales Model
8.5.2 Sales Channel
8.5.3 OTC Veterinary Drug Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Zoetis
Boehringer Ingelheim
Virbac S.A.
Hester Biosciences Ltd.
Merck Animal Health
Elanco Animal Health
Ceva Sant茅 Animale
Vetoquinol S.A.
Phibro Animal Health Corporation
Dechra Pharmaceuticals PLC

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.